| Financial Year |
March 31 2023 |
| Monetary Funds |
2,124,981,719.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,717,545,159.45 |
| Accounts Receivable |
9,623,194,863.39 |
| Advances to Suppliers |
2,277,103,479.21 |
| Other Receivables |
1,132,614,760.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
6,824,721.01 |
| Inventories |
6,606,299,019.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
202,498,947.86 |
| Total Current Assets |
30,176,111,712.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,695,328,123.27 |
| Investment Properties |
912,678.06 |
| Fixed Assetes |
6,505,632,211.38 |
| Under-construction Projects |
403,982,885.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,922,925,774.88 |
| R&D expenses |
318,167,117.77 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,868,075.66 |
| Deferred Income Tax Assets |
199,790,191.18 |
| Other Non-Current Assets |
496,511,396.88 |
| Sub-Total of Non-Current Assets |
14,141,511,995.55 |
| Total Assets |
44,317,623,708.37 |
| Short-Term Loans |
5,796,502,670.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,134,301,071.28 |
| Accounts Payable |
8,626,506,251.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
402,702,412.23 |
| Taxes Payable |
132,111,045.80 |
| Interest Payable |
-- |
| Dividend Payable |
1,224,627.32 |
| Other payables |
356,166,932.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,217,363,857.27 |
| Other Current Liabilities |
468,729,666.08 |
| Sub-Total of Current Liabilities |
22,517,744,481.68 |
| Long-term Loans |
8,890,849,293.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
84,778,032.75 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
26,816,409.15 |
| Sub-Total of Non-Current Liabilities |
9,895,767,674.07 |
| Total Liabilities |
32,413,512,155.75 |
| Paid-In Capital(Or Share Stock) |
6,857,782,927.00 |
| Capital Surplus |
9,618,170,658.68 |
| Surplus Reserve |
125,689,638.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,187,715,622.68 |
| Minority Stockholder's Interest |
152,573,278.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,751,538,274.49 |
| Owner's Equity（Stockholder's Equity） |
11,904,111,552.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
44,317,623,708.37 |
